Aviva PLC Alnylam Pharmaceuticals, Inc. Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Aviva PLC holds 24,506 shares of ALNY stock, worth $5.83 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,506

Previous 10,891 125.01%

Holding current value

$5.83 Million

Previous $2.65 Million 154.76%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$233.81 - $287.01 $3.18 Million - $3.91 Million	13,615 Added 125.01%	24,506 $6.74 Million
Q2 2024 Aug 02, 2024	BUY	$143.31 - $247.0 $876,054 - $1.51 Million	6,113 Added 127.94%	10,891 $2.65 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $461,359 - $624,131	-3,149 Reduced 39.72%	4,778 $714,000
Q4 2023 Feb 09, 2024	SELL	$151.41 - $196.57 $3.1 Million - $4.03 Million	-20,481 Reduced 72.1%	7,927 $1.52 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $3.49 Million - $4.33 Million	20,451 Added 257.02%	28,408 $5.03 Million
Q2 2023 Aug 10, 2023	SELL	$185.01 - $212.05 $18.4 Million - $21 Million	-99,215 Reduced 92.58%	7,957 $1.51 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $4.14 Million - $5.34 Million	-22,668 Reduced 17.46%	107,172 $21.5 Million
Q4 2022 Feb 09, 2023	BUY	$185.53 - $241.31 $7.86 Million - $10.2 Million	42,365 Added 48.43%	129,840 $30.9 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $638,669 - $1.07 Million	4,610 Added 5.56%	87,475 $17.5 Million
Q2 2022 Aug 04, 2022	BUY	$120.42 - $169.29 $1.18 Million - $1.66 Million	9,825 Added 13.45%	82,865 $12.1 Million
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $4.43 Million - $6.06 Million	34,823 Added 91.12%	73,040 $11.9 Million
Q4 2021 Feb 10, 2022	BUY	$159.56 - $209.29 $313,535 - $411,254	1,965 Added 5.42%	38,217 $6.48 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $606,177 - $741,803	-3,571 Reduced 8.97%	36,252 $6.85 Million
Q2 2021 Aug 10, 2021	BUY	$128.63 - $176.89 $179,567 - $246,938	1,396 Added 3.63%	39,823 $6.75 Million
Q1 2021 May 13, 2021	SELL	$126.83 - $175.69 $1.22 Million - $1.69 Million	-9,613 Reduced 20.01%	38,427 $5.43 Million
Q4 2020 Feb 10, 2021	SELL	$122.97 - $147.0 $753,191 - $900,375	-6,125 Reduced 11.31%	48,040 $6.24 Million
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $96,830 - $132,226	799 Added 1.5%	54,165 $7.89 Million
Q2 2020 Aug 13, 2020	SELL	$104.21 - $156.44 $597,123 - $896,401	-5,730 Reduced 9.7%	53,366 $7.9 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $3.14 Million - $4.52 Million	33,759 Added 133.24%	59,096 $6.43 Million
Q4 2019 Feb 10, 2020	SELL	$74.51 - $124.23 $120,557 - $201,004	-1,618 Reduced 6.0%	25,337 $2.92 Million
Q3 2019 Nov 12, 2019	SELL	$70.9 - $87.82 $820,880 - $1.02 Million	-11,578 Reduced 30.05%	26,955 $2.17 Million
Q2 2019 Jul 30, 2019	BUY	$65.86 - $92.79 $255,668 - $360,210	3,882 Added 11.2%	38,533 $2.8 Million
Q1 2019 May 14, 2019	BUY	$72.76 - $93.45 $90,877 - $116,719	1,249 Added 3.74%	34,651 $3.24 Million
Q4 2018 Feb 12, 2019	SELL	$62.67 - $88.33 $566,787 - $798,856	-9,044 Reduced 21.31%	33,402 $2.44 Million
Q3 2018 Nov 13, 2018	SELL	$87.52 - $122.67 $120,777 - $169,284	-1,380 Reduced 3.15%	42,446 $3.72 Million
Q2 2018 Aug 01, 2018	SELL	$88.31 - $107.8 $2,560 - $3,126	-29 Reduced 0.07%	43,826 $4.32 Million
Q1 2018 May 14, 2018	BUY	$115.92 - $148.54 $5.08 Million - $6.51 Million	43,855 New	43,855 $5.22 Million

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account